Updated: Sep 11, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Takehiko Ueda1, Ryo Kobayashi1, Nobuhiro Kasai2
1Solution Planning Department, Healthcare Business Unit, Nikon Corporation, 1-5-20 Nishioi, Shinagawa-ku, Tokyo, 140-8601, Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A new label-free method uses bright-field microscopy and deep learning to predict Chimeric Antigen Receptor T (CAR-T)-cell expression rates. This approach offers accurate, real-time monitoring for CAR-T cell therapy manufacturing and research.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: